DOSSIER · 13F Holders · Q3 2026Healthcare · Pharmaceutical Preparations
REGN
REGENERON PHARMACEUTICALS
1,509 institutions still hold REGENERON PHARMACEUTICALS as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 75886F107·Pharmaceutical Preparations·1,509 13F holders·last filed Sep 30, 2026
AI Holders Summary · Q3 2026
1,509 institutions reported REGN in Q3 2026. BlackRock, Inc. leads at 9.6% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 76
1489 more holders available. Log in →